Title: Pediatric <i>TTMV::RARA</i>‐positive relapsed acute promyelocytie leukemia responsive to venetoclax and achieving long remission after allogenic transplantation
Abstract: Pediatric Blood & CancerVolume 70, Issue 12 e30665 LETTER TO THE EDITOR Pediatric TTMV::RARA-positive relapsed acute promyelocytie leukemia responsive to venetoclax and achieving long remission after allogenic transplantation Jiaqi Chen, Jiaqi Chen orcid.org/0000-0002-0252-7987 Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorXiaosu Zhou, Xiaosu Zhou orcid.org/0000-0002-9220-0442 Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, ChinaSearch for more papers by this authorXue Chen, Xue Chen orcid.org/0000-0002-1282-3405 Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorQihui Chen, Qihui Chen Department of Research and Development, Beijing Geneprofile Technologies Co., Ltd, Beijing, ChinaSearch for more papers by this authorJunfang Yang, Junfang Yang Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorYue Lu, Yue Lu Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorHongxing Liu, Corresponding Author Hongxing Liu [email protected] orcid.org/0000-0002-0547-5721 Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China Department of Oncology, Capital Medical University, Beijing, China Correspondence Hongxing Liu, Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, 100176 Beijing, China. Email: [email protected]Search for more papers by this author Jiaqi Chen, Jiaqi Chen orcid.org/0000-0002-0252-7987 Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorXiaosu Zhou, Xiaosu Zhou orcid.org/0000-0002-9220-0442 Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, ChinaSearch for more papers by this authorXue Chen, Xue Chen orcid.org/0000-0002-1282-3405 Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorQihui Chen, Qihui Chen Department of Research and Development, Beijing Geneprofile Technologies Co., Ltd, Beijing, ChinaSearch for more papers by this authorJunfang Yang, Junfang Yang Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorYue Lu, Yue Lu Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaSearch for more papers by this authorHongxing Liu, Corresponding Author Hongxing Liu [email protected] orcid.org/0000-0002-0547-5721 Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China Department of Oncology, Capital Medical University, Beijing, China Correspondence Hongxing Liu, Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, 100176 Beijing, China. Email: [email protected]Search for more papers by this author First published: 16 September 2023 https://doi.org/10.1002/pbc.30665 These authors from Beijing Lu Daopei Institute of Hematology (BLDIH) and Hebei Yanda Lu Daopei Hospital (HYLDH) also contributed to this study: Panxiang Cao (BLDIH, HYLDH), Fang Wang (HYLDH), Yang Zhang (BLDIH, HYLDH), Jiancheng Fang (HYLDH), Xiaoli Ma (HYLDH), Xiujuan Ma (HYLDH), Mingyue Liu (HYLDH), Lili Yuan (HYLDH), Ming Liu (HYLDH), Siyuan Liu (BLDIH), Ping Wu (HYLDH), Mingyue Liu (HYLDH), Siyuan Liu (HYLDH) . Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Astolfi A, Masetti R, Indio V, et al. Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion. Blood. 2021; 138(18): 1773-1777. 2Sala-Torra O, Beppu LW, Abukar FA, et al. TTMV-RARA fusion as a recurrent cause of AML with APL characteristics. Blood Adv. 2022; 6(12): 3590-3592. 3Chen X, Wang F, Zhou X, et al. Torque teno mini virus driven childhood acute promyelocytic leukemia: the third case report and sequence analysis. Front Oncol. 2022; 12:1074913. 4Chen X, Wang F, Zhang Y, et al. Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients. Leuk Lymphoma. 2019; 60(4): 1071-1078. 5 Pediatric Oncology Committee, China Anti-Cancer Association (CCCG). Chinese guideline for diagnosis and treatment of childhood acute promyelocytic leukemia. Chin J Appl Clin Pediatr. 2022; 37(2): 81-88. 6Chen X, Wang F, Zhang Y, et al. Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. Blood Cancer J. 2021; 11(6): 112. 7Tomita A, Kiyoi H, Naoe T. Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia. Int J Hematol. 2013; 97(6): 717-725. 8Madan V, Shyamsunder P, Han L, et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. 2016; 30(8): 1672-1681. Volume70, Issue12December 2023e30665 ReferencesRelatedInformation
Publication Year: 2023
Publication Date: 2023-09-16
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 3
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot